Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients

Disease Markers

Volumn 34, Issue 4, 2013, Pages 229-235

  Lee, Chien Te ^a   Chua, Sarah ^a   Hsu, Chung Yao ^b   Tsai, Yu Che ^a   Ng, Hwee Yeong ^a   Kuo, Chien Chun ^a   Wu, Chien Hsing ^a   Chen, Te Chun ^a   Chiu, Terry Ting Yu ^a   Lee, Yueh Ting ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

biomarker; hemodialysis; valvular calcification; Vascular calcification

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; CHOLESTEROL; FETUIN A; FIBROBLAST GROWTH FACTOR 23; HEMOGLOBIN; INTERLEUKIN 6; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE; SERUM ALBUMIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; AORTA VALVE CALCIFICATION; ARTERIAL INTIMAL CALCIFICATION; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIFICATION; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE CALCIFICATION; PARATHYROID HORMONE BLOOD LEVEL; PELVIS RADIOGRAPHY; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84876241376     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/846059     Document Type: Article

References (32)

1. Tsai YC, Lee CT, Huang TL, Cheng BC, Kuo CC, Su Y, Ng HY, Yang CC, Chuang FR, Liao SC. Inflammatory marker but not adipokine predicts mortality among long-term hemodialysis patients. Mediators Inflamm 2007; 2007: 19891-19895.
2. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
3. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in longterm peritoneal dialysis patients: A prospective study. J Am Soc Nephrol 2003; 14: 159-168. (Pubitemid 36032720)
4. Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond WS. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977; 86: 403-424. (Pubitemid 8035039)
5. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P. Effects of sevelamer and calcium n coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824. (Pubitemid 43169927)
6. Dellegrottaglie S, Sanz J, Rajagopalan S. Molecular determinants of vascular calcification: A bench to bedside view. Curr Mol Med 2006; 6: 515-524.
7. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME.Medial localization of mineralizationregulating proteins in association with Mönckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100: 2168-2176.
8. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: An early perspective. Am J Physiol Endocrine Metab 2004; 286: E686-696. (Pubitemid 38506938)
9. Wang AY, Ho SS, Wang M, Liu EK, Ho S, Li PK, Lui SF, Sanderson JE. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med 2005; 165: 327-332. (Pubitemid 40216288)
10. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
11. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: The killer of patients with chronic kidney disease. J Am Soc Nephrol 2009; 20: 1453-1464.
12. Lee CT, Tsai YC, Su CY, Ng HY, Hsu CY, Ko SF, Chen TC, Kuo CC, Yang CC, Chiou TY, Lee WC, Yang YK, Lam KK. Interleukin 10 and residual kidney function are associated with risk of vascular calcification in patients undergoing peritoneal dialysis. Clinical Nephrology 2011; 75: 397-402.
13. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534. (Pubitemid 15248043)
14. Ribeiro S, Ramos A, Brandão A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remédio F, Ribeiro F. Cardiac valve calcification in haemodialysis patients: role of calciumphosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037-2040. (Pubitemid 28356772)
15. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2: 875-877. (Pubitemid 17154752)
16. Ikee R, Honda K, Oka M, Maesato K, Mano T, Moriya H, Ohtake T, Kobayashi S. Association of heart valve calcification with malnutrition-inflammation complex syndrome, betamicroglobulin, and carotid intima media thickness in patients on hemodialysis. Ther Apher Dial 2008; 12: 464-468.
17. Cozzolino M,Mazzaferro S, Pugliese F, Brancaccio D. Vascular calcification and uremia: what do we know? Am J Nephrol 2008; 28: 339-346.
18. Lee CT, Tsai YC, Ng HY, Su Y, Lee WC, Lee LC, Chiou TT, Liao SC, Hsu KT. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: A cross-sectional study. J Ren Nutr 2009; 19: 220-227.
19. Wang AY, Lam CW, Wang M, Chan IH, Yu CM, Lui SF, Sanderson JE. Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in endstage renal disease: A prospective cohort study. Am J Nephrol 2008; 28: 647-653. (Pubitemid 351832452)
20. Kasifoglue T, Cansu D, Korkmaz C. Widespread arterial calcification in a patient with gout. Intern Med. 2008; 47: 481. (Pubitemid 351663711)
21. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogenactivated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-1293. (Pubitemid 36706079)
22. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005; 25: 39-42. (Pubitemid 40128147)
23. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95: 1046-1057. (Pubitemid 39557891)
24. Mesquita M, Demulder A, Damry N, Méot C, Wittersheim E, Willems D, Dratwa M, Bergmann P. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med 2009; 47: 339-346.
25. Demer LL, Tintut Y. Vascular calcification: Pathobiology of a multifaceted disease. Circulation 2008; 117: 2938-2948. (Pubitemid 351787058)
26. Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148. (Pubitemid 41828276)
27. Metry G, Stenvinkel P, Qureshi AR, Carrero JJ, Yilmaz MI, Bárány P, Snaedal S, Heimbürger O, Lindholm B, Suliman ME. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients. Eur J Clin Invest 2008; 38: 804-811.
28. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CK, Hoeks AP, Floege J, Leunissen KM. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 2006; 21: 1293-1299.
29. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004; 65: 1943-1946. (Pubitemid 38591047)
30. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592.
31. Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y. Role of fibroblast growth factor-23 in peripheral vascular calcification in nondiabetic and diabetic hemodialysis patients. Osteoporos Int 2006; 17: 1506-1513. (Pubitemid 44387485)
32. Morena M, Jaussent I, Halkovich A, Dupuy AM, Bargnoux AS, Chenine L, Leray-Moragues H, Klouche K, Vernhet H, Canaud B, Cristol JP. Bone biomarkers help grading severity of coronary calcification in non dialysis chronic kidney disease patients. PLoS One 2012; 7: e36175.